Skip to main content
Top

2016 | OriginalPaper | Hoofdstuk

10 Reumatische ziekten en hemofilie op de kinderleeftijd

B Hemofilie

Auteurs : Danielle C. M. Douma-van Riet, Marjon H. Cnossen

Gepubliceerd in: Kinderfysiotherapie

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Hemofilie is een zeldzame erfelijke stollingsstoornis waarbij er sprake is van een tekort aan stollingsfactor VIII of IX, respectievelijk hemofilie A of B. De ernst van de ziekte wordt bepaald door de restactiviteit van de ontbrekende stollingsfactor.
Literatuur
1.
go back to reference Fijnvandraat K, Cnossen MH, Leebeek FW, Peters M. Diagnosis and management of haemophilia. BMJ. 2012;344:e2707.CrossRefPubMed Fijnvandraat K, Cnossen MH, Leebeek FW, Peters M. Diagnosis and management of haemophilia. BMJ. 2012;344:e2707.CrossRefPubMed
2.
go back to reference Leebeek FWG, Mauser-Bunschoten EP. Richtlijn Diagnostiek en behandeling van hemofilie en aanverwante hemostasestoornissen (NVHB). Alphen aan den Rijn: Van Zuiden, 2009. Leebeek FWG, Mauser-Bunschoten EP. Richtlijn Diagnostiek en behandeling van hemofilie en aanverwante hemostasestoornissen (NVHB). Alphen aan den Rijn: Van Zuiden, 2009.
3.
go back to reference Hegeman AK, Genderen FR van, Meijer S, et al. Perceived competence in children and adolescents with haemophilia: an explorative study. Haemophilia. 2011;17:81-9.CrossRefPubMed Hegeman AK, Genderen FR van, Meijer S, et al. Perceived competence in children and adolescents with haemophilia: an explorative study. Haemophilia. 2011;17:81-9.CrossRefPubMed
4.
go back to reference Douma-van Riet DC, Engelbert RH, Genderen FR van, et al. Physical fitness in children with haemophilia and the effect of overweight. Haemophilia. 2009;15:519-27.CrossRefPubMed Douma-van Riet DC, Engelbert RH, Genderen FR van, et al. Physical fitness in children with haemophilia and the effect of overweight. Haemophilia. 2009;15:519-27.CrossRefPubMed
5.
go back to reference Koiter J, Genderen FR van, Brons PP, Nijhuis-van der Sanden MW. Participation and risk-taking behaviour in sports in children with haemophilia. Haemophilia. 2009;15:686-94.CrossRefPubMed Koiter J, Genderen FR van, Brons PP, Nijhuis-van der Sanden MW. Participation and risk-taking behaviour in sports in children with haemophilia. Haemophilia. 2009;15:686-94.CrossRefPubMed
6.
go back to reference Oostrom C van, Kamps W. In: Brande JL van den, Heymans HSA, Monnens LAH, red. Kindergeneeskunde, 3e dr. Maarssen: Elsevier gezondheidszorg, 1998. Oostrom C van, Kamps W. In: Brande JL van den, Heymans HSA, Monnens LAH, red. Kindergeneeskunde, 3e dr. Maarssen: Elsevier gezondheidszorg, 1998.
7.
go back to reference Lee C, Berntrop E, Hoots W. Textbook of hemophilia. Oxford: Blackwell, 2005.CrossRef Lee C, Berntrop E, Hoots W. Textbook of hemophilia. Oxford: Blackwell, 2005.CrossRef
8.
go back to reference Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357:535-44.CrossRefPubMed Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357:535-44.CrossRefPubMed
9.
go back to reference Berg HM van den, Fischer K, Mauser-Bunschoten EP, et al. Long-term outcome of individualized prophylactic treatment of children with severe haemophilia. Br J Haematol. 2001;112:561-5.CrossRefPubMed Berg HM van den, Fischer K, Mauser-Bunschoten EP, et al. Long-term outcome of individualized prophylactic treatment of children with severe haemophilia. Br J Haematol. 2001;112:561-5.CrossRefPubMed
11.
go back to reference Acharya SS. Exploration of the pathogenesis of haemophilic joint arthropathy: understanding implications for optimal clinical management. Br J Haematol. 2012;156:13-23.CrossRefPubMed Acharya SS. Exploration of the pathogenesis of haemophilic joint arthropathy: understanding implications for optimal clinical management. Br J Haematol. 2012;156:13-23.CrossRefPubMed
12.
go back to reference Gilbert MS. Musculoskeletal complications of haemophilia: the joint. Haemophilia. 2000;6(Suppl 1):34-7.CrossRefPubMed Gilbert MS. Musculoskeletal complications of haemophilia: the joint. Haemophilia. 2000;6(Suppl 1):34-7.CrossRefPubMed
13.
go back to reference Hooiveld MJ, Roosendaal G, Jacobs KM, et al. Initiation of degenerative joint damage by experimental bleeding combined with loading of the joint: a possible mechanism of hemophilic arthropathy. Arthritis Rheum. 2004;50:2024-31.CrossRefPubMed Hooiveld MJ, Roosendaal G, Jacobs KM, et al. Initiation of degenerative joint damage by experimental bleeding combined with loading of the joint: a possible mechanism of hemophilic arthropathy. Arthritis Rheum. 2004;50:2024-31.CrossRefPubMed
15.
go back to reference Rodriguez-Merchan EC. Cartilage damage in the haemophilic joints: pathophysiology, diagnosis and management. Blood Coagul Fibrinolysis. 2012;23:179-83.CrossRefPubMed Rodriguez-Merchan EC. Cartilage damage in the haemophilic joints: pathophysiology, diagnosis and management. Blood Coagul Fibrinolysis. 2012;23:179-83.CrossRefPubMed
16.
go back to reference Sorensen B, Benson GM, Bladen M, et al. Management of muscle haematomas in patients with severe haemophilia in an evidence-poor world. Haemophilia. 2012;18:598-606.CrossRefPubMed Sorensen B, Benson GM, Bladen M, et al. Management of muscle haematomas in patients with severe haemophilia in an evidence-poor world. Haemophilia. 2012;18:598-606.CrossRefPubMed
17.
go back to reference Heim M, Beeton K, Blamey G, Goddard N. Management of the elbow joint. Haemophilia. 2012;18(Suppl 4):101-4.CrossRefPubMed Heim M, Beeton K, Blamey G, Goddard N. Management of the elbow joint. Haemophilia. 2012;18(Suppl 4):101-4.CrossRefPubMed
19.
go back to reference Groen W, Net J van der, Bos K, et al. Joint health and functional ability in children with haemophilia who receive intensive replacement therapy. Haemophilia. 2011;17:783-90.PubMed Groen W, Net J van der, Bos K, et al. Joint health and functional ability in children with haemophilia who receive intensive replacement therapy. Haemophilia. 2011;17:783-90.PubMed
20.
go back to reference Feldman BM, Funk SM, Bergstrom BM, et al. Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: validity of the hemophilia joint health score. Arthritis Care Res (Hoboken). 2011;63:223-30.CrossRefPubMed Feldman BM, Funk SM, Bergstrom BM, et al. Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: validity of the hemophilia joint health score. Arthritis Care Res (Hoboken). 2011;63:223-30.CrossRefPubMed
21.
go back to reference Hilliard P, Funk S, Zourikian N, et al. Hemophilia joint health score reliability study. Haemophilia. 2006;12:518-25.CrossRefPubMed Hilliard P, Funk S, Zourikian N, et al. Hemophilia joint health score reliability study. Haemophilia. 2006;12:518-25.CrossRefPubMed
22.
go back to reference Stephensen D, Drechsler W, Scott O. Comparison of muscle strength and in-vivo muscle morphology in young children with haemophilia and those of agematched peers. Haemophilia. 2012;18:e302-10.CrossRefPubMed Stephensen D, Drechsler W, Scott O. Comparison of muscle strength and in-vivo muscle morphology in young children with haemophilia and those of agematched peers. Haemophilia. 2012;18:e302-10.CrossRefPubMed
23.
go back to reference von Mackensen S, Bullinger M. Development and testing of an instrument to assess the Quality of Life of Children with Haemophilia in Europe (Haemo-QoL). Haemophilia. 2004;10(Suppl 1):17-25.CrossRef von Mackensen S, Bullinger M. Development and testing of an instrument to assess the Quality of Life of Children with Haemophilia in Europe (Haemo-QoL). Haemophilia. 2004;10(Suppl 1):17-25.CrossRef
24.
go back to reference Young NL, Bradley CS, Wakefield CD, et al. How well does the Canadian Haemophilia Outcomes-Kids’ Life Assessment Tool (CHO-KLAT) measure the quality of life of boys with haemophilia? Pediatr Blood Cancer. 2006;47:305-11.CrossRefPubMed Young NL, Bradley CS, Wakefield CD, et al. How well does the Canadian Haemophilia Outcomes-Kids’ Life Assessment Tool (CHO-KLAT) measure the quality of life of boys with haemophilia? Pediatr Blood Cancer. 2006;47:305-11.CrossRefPubMed
25.
go back to reference Custers JW, Net J van der, Hoijtink H, et al. Discriminative validity of the Dutch Pediatric Evaluation of Disability Inventory. Arch Phys Med Rehabil. 2002;83:1437-41.CrossRefPubMed Custers JW, Net J van der, Hoijtink H, et al. Discriminative validity of the Dutch Pediatric Evaluation of Disability Inventory. Arch Phys Med Rehabil. 2002;83:1437-41.CrossRefPubMed
26.
go back to reference Buzzard B, Keeton K. Physiotherapy managment of haemophilia. Oxford: Blackwell, 2000.CrossRef Buzzard B, Keeton K. Physiotherapy managment of haemophilia. Oxford: Blackwell, 2000.CrossRef
27.
go back to reference Schoenmakers MA, Gulmans VA, Helders PJ, Berg HM van den. Motor performance and disability in Dutch children with haemophilia: a comparison with their healthy peers. Haemophilia. 2001;7:293-8.CrossRefPubMed Schoenmakers MA, Gulmans VA, Helders PJ, Berg HM van den. Motor performance and disability in Dutch children with haemophilia: a comparison with their healthy peers. Haemophilia. 2001;7:293-8.CrossRefPubMed
Metagegevens
Titel
10 Reumatische ziekten en hemofilie op de kinderleeftijd
Auteurs
Danielle C. M. Douma-van Riet
Marjon H. Cnossen
Copyright
2016
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-1592-5_20